145 related articles for article (PubMed ID: 25089836)
1. A spatiotemporally defined in vitro microenvironment for controllable signal delivery and drug screening.
Kuo CT; Liu HK; Huang GS; Chang CH; Chen CL; Chen KC; Huang RY; Lin CH; Lee H; Huang CS; Wo AM
Analyst; 2014 Oct; 139(19):4846-54. PubMed ID: 25089836
[TBL] [Abstract][Full Text] [Related]
2. A microchip filter device incorporating slit arrays and 3-D flow for detection of circulating tumor cells using CAV1-EpCAM conjugated microbeads.
Kim YJ; Koo GB; Lee JY; Moon HS; Kim DG; Lee DG; Lee JY; Oh JH; Park JM; Kim MS; Woo HG; Kim SI; Kang P; Choi W; Sim TS; Park WY; Lee JG; Kim YS
Biomaterials; 2014 Aug; 35(26):7501-10. PubMed ID: 24917030
[TBL] [Abstract][Full Text] [Related]
3. Epithelial-to-mesenchymal transition induced by TGF-β1 is mediated by AP1-dependent EpCAM expression in MCF-7 cells.
Gao J; Yan Q; Wang J; Liu S; Yang X
J Cell Physiol; 2015 Apr; 230(4):775-82. PubMed ID: 25205054
[TBL] [Abstract][Full Text] [Related]
4. Patterning hypoxic multicellular spheroids in a 3D matrix - a promising method for anti-tumor drug screening.
Ma J; Zhang X; Liu Y; Yu H; Liu L; Shi Y; Li Y; Qin J
Biotechnol J; 2016 Jan; 11(1):127-34. PubMed ID: 26647062
[TBL] [Abstract][Full Text] [Related]
5. Modeling of cancer metastasis and drug resistance via biomimetic nano-cilia and microfluidics.
Kuo CT; Chiang CL; Chang CH; Liu HK; Huang GS; Huang RY; Lee H; Huang CS; Wo AM
Biomaterials; 2014 Feb; 35(5):1562-71. PubMed ID: 24269156
[TBL] [Abstract][Full Text] [Related]
6. Context-dependent adaption of EpCAM expression in early systemic esophageal cancer.
Driemel C; Kremling H; Schumacher S; Will D; Wolters J; Lindenlauf N; Mack B; Baldus SA; Hoya V; Pietsch JM; Panagiotidou P; Raba K; Vay C; Vallböhmer D; Harréus U; Knoefel WT; Stoecklein NH; Gires O
Oncogene; 2014 Oct; 33(41):4904-15. PubMed ID: 24141784
[TBL] [Abstract][Full Text] [Related]
7. Biofabrication of a three-dimensional liver micro-organ as an in vitro drug metabolism model.
Chang R; Emami K; Wu H; Sun W
Biofabrication; 2010 Dec; 2(4):045004. PubMed ID: 21079286
[TBL] [Abstract][Full Text] [Related]
8. Microfluidic co-culture of liver tumor spheroids with stellate cells for the investigation of drug resistance and intercellular interactions.
Chen Y; Sun W; Kang L; Wang Y; Zhang M; Zhang H; Hu P
Analyst; 2019 Jul; 144(14):4233-4240. PubMed ID: 31210202
[TBL] [Abstract][Full Text] [Related]
9. Acquisition of epithelial-mesenchymal transition and cancer stem-like phenotypes within chitosan-hyaluronan membrane-derived 3D tumor spheroids.
Huang YJ; Hsu SH
Biomaterials; 2014 Dec; 35(38):10070-9. PubMed ID: 25282622
[TBL] [Abstract][Full Text] [Related]
10. Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial-mesenchymal transition in hepatocellular carcinoma.
Fan QM; Jing YY; Yu GF; Kou XR; Ye F; Gao L; Li R; Zhao QD; Yang Y; Lu ZH; Wei LX
Cancer Lett; 2014 Oct; 352(2):160-8. PubMed ID: 24892648
[TBL] [Abstract][Full Text] [Related]
11. EpCAM is up-regulated by EGF via ERK1/2 signaling and suppresses human epithelial ovarian cancer cell migration.
Fan Q; Cheng JC; Qiu X; Chang HM; Leung PC
Biochem Biophys Res Commun; 2015 Feb; 457(3):256-61. PubMed ID: 25576358
[TBL] [Abstract][Full Text] [Related]
12. EpCAM expression in the prostate cancer makes the difference in the response to growth factors.
Yoshida GJ; Saya H
Biochem Biophys Res Commun; 2014 Jan; 443(1):239-45. PubMed ID: 24309103
[TBL] [Abstract][Full Text] [Related]
13. Screening therapeutic EMT blocking agents in a three-dimensional microenvironment.
Aref AR; Huang RY; Yu W; Chua KN; Sun W; Tu TY; Bai J; Sim WJ; Zervantonakis IK; Thiery JP; Kamm RD
Integr Biol (Camb); 2013 Feb; 5(2):381-9. PubMed ID: 23172153
[TBL] [Abstract][Full Text] [Related]
14. Development of a magnetic 3D spheroid platform with potential application for high-throughput drug screening.
Guo WM; Loh XJ; Tan EY; Loo JS; Ho VH
Mol Pharm; 2014 Jul; 11(7):2182-9. PubMed ID: 24842574
[TBL] [Abstract][Full Text] [Related]
15. Epithelial cell adhesion molecule (EpCAM) is associated with prostate cancer metastasis and chemo/radioresistance via the PI3K/Akt/mTOR signaling pathway.
Ni J; Cozzi P; Hao J; Beretov J; Chang L; Duan W; Shigdar S; Delprado W; Graham P; Bucci J; Kearsley J; Li Y
Int J Biochem Cell Biol; 2013 Dec; 45(12):2736-48. PubMed ID: 24076216
[TBL] [Abstract][Full Text] [Related]
16. A parallel-gradient microfluidic chamber for quantitative analysis of breast cancer cell chemotaxis.
Saadi W; Wang SJ; Lin F; Jeon NL
Biomed Microdevices; 2006 Jun; 8(2):109-18. PubMed ID: 16688570
[TBL] [Abstract][Full Text] [Related]
17. A microengineered pathophysiological model of early-stage breast cancer.
Choi Y; Hyun E; Seo J; Blundell C; Kim HC; Lee E; Lee SH; Moon A; Moon WK; Huh D
Lab Chip; 2015 Aug; 15(16):3350-7. PubMed ID: 26158500
[TBL] [Abstract][Full Text] [Related]
18. Detachably assembled microfluidic device for perfusion culture and post-culture analysis of a spheroid array.
Sakai Y; Hattori K; Yanagawa F; Sugiura S; Kanamori T; Nakazawa K
Biotechnol J; 2014 Jul; 9(7):971-9. PubMed ID: 24802801
[TBL] [Abstract][Full Text] [Related]
19. 3D models of epithelial-mesenchymal transition in breast cancer metastasis: high-throughput screening assay development, validation, and pilot screen.
Li Q; Chen C; Kapadia A; Zhou Q; Harper MK; Schaack J; LaBarbera DV
J Biomol Screen; 2011 Feb; 16(2):141-54. PubMed ID: 21297102
[TBL] [Abstract][Full Text] [Related]
20. Epithelial-to-mesenchymal transition of human lung alveolar epithelial cells in a microfluidic gradient device.
Kim SH; Hwang SM; Lee JM; Kang JH; Chung IY; Chung BG
Electrophoresis; 2013 Feb; 34(3):441-7. PubMed ID: 23161566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
